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Summary
The pathogenicity of mycobacterial infections
depends on virulence factors that mediate survival
inside host macrophages. These virulence factors
are generally believed to be speciﬁc for pathogenic
species and absent or mutated in non-pathogenic
strains. The serine/threonine protein kinase G (PknG)
mediates survival of mycobacteria within macro-
phages by blocking lysosomal delivery. Here we
describe a gene of the non-pathogenic species Myco-
bacterium smegmatis that is 78% identical with pknG
of Mycobacterium tuberculosis and M. bovis bacillus
Calmette–Guérin (BCG). When cloned into expression
vectors, the M. smegmatis pknG orthologue produced
an active kinase and performed the same function as
its M. bovis BCG counterpart in intracellular survival.
In addition, similar levels of pknG transcripts were
found in M. bovis BCG and M. smegmatis. However,
virtually no translation product of chromosomal pknG
could be detected in M. smegmatis both after in vitro
growth and after macrophage infection. This lack of
efficient translation was shown to be caused by
regulatory elements in the upstream region of the
M. smegmatis gene. The data reveal dramatically
increased translational efficiency of a virulence gene
in a pathogenic mycobacterium compared with a non-
pathogenic mycobacterium suggesting that changes
in expression levels may underlie evolution of pknG
and other pathogenicity genes in mycobacterium.
Introduction
Pathogenic mycobacteria, such as Mycobacterium tuber-
culosis, utilize an array of different strategies to survive
inside mammalian host cells. Survival strategies are
employed during the initial phases of the infection when
the bacteria acquire access to their host cells, as well as
during later stages of infection as the bacteria convert into
a so-called dormant or latent state (Cosma et al., 2003). In
the initial phases of infection, it is important that mycobac-
teria gain entry to macrophages, as they have the unique
capacity to avoid antibacterial effectors of the immune
system in this intracellular niche (Russell, 2001; Vergne
et al., 2004; Houben et al., 2006). To ensure survival
inside macrophages, pathogenic mycobacteria avoid their
degradation by actively inhibiting fusion of the mycobac-
terial phagosome with lysosomes (Armstrong and Hart,
1971; Russell, 2001; Houben et al., 2006).
The molecular mechanisms that are responsible for
diverting the traffic of pathogenic mycobacteria from the
lysosomal degradative pathway are beginning to be
understood and both host factors and mycobacterial mol-
ecules are involved in this process (Vergne et al., 2004;
Houben et al., 2006). The eukaryotic-like serine/threonine
kinase, protein kinase G (PknG), is one of the mycobac-
terial factors involved in blocking lysosomal delivery (Wal-
burger et al., 2004; Scherr et al., 2007). Although it has
been reported that PknG in M. tuberculosis and a related
microorganism (Corynebacterium glutamicum) is required
for optimal in vitro growth and is linked to intracellular
glutamine/glutamate levels (Cowley et al., 2004; Niebisch
et al., 2006), PknG in Mycobacterium bovis bacillus
Calmette–Guérin (BCG) has been shown not to be
required for mycobacterial growth outside macrophages
in a complete liquid medium and not to be involved in
glutamine metabolism (Walburger et al., 2004; Nguyen
et al., 2005). After their uptake within macrophage
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PknG are readily transported to lysosomes and destroyed
(Walburger et al., 2004 and data not shown).
Interestingly, also the non-pathogenic Mycobacterium
smegmatis genome contains a gene that is very similar to
M. tuberculosis and M. bovis pknG. We here characterize
the gene product from M. smegmatis pknG, showing that it
encodes an active serine/threonine kinase and is able to
block the lysosomal delivery of mycobacteria inside mac-
rophages when expressed from expression vectors. How-
ever, while PknG transcripts were found in M. smegmatis,
chromosomal pknG was not effectively translated in this
non-pathogenic mycobacterium.The data show that PknG
expression is blocked on a translational level in M. smeg-
matis and suggest that translational efficiency is an impor-
tant factor in assessing candidate virulence genes.
Results
Mycobacterial PknG orthologues
The mycobacterial serine/threonine kinase PknG is
required for survival of pathogenic mycobacteria inside
macrophages(Walburgeretal.,2004).Toanalysewhether
the presence of PknG is speciﬁc for pathogenic mycobac-
teria, all available mycobacterial genome sequences,
i.e. of M. tuberculosis, M. bovis (BCG), M. microti,
M. marinum, M. avium (paratuberculosis), M. leprae and
M. smegmatis, were analysed for the presence of a locus
encoding pknG orthologues (Fig. 1).All of these genomes
encoded an open reading frame that was highly homolo-
gous to PknG of M. tuberculosis. Strikingly, the genome of
the non-pathogenic M. smegmatis also encodes a pknG
orthologue (named MSMEG_0786) showing 78% identity
and87%similaritytoM. tuberculosisPknG.Inaddition,the
postulated operon structure around the pknG gene is
conserved in M. smegmatis as well (see also Fig. 8A). For
all PknGs, the homology extends over the kinase domain
(residues 141–398 of M. tuberculosis PknG) as well as the
C-terminal region, with the only deviation from homology
within the N-terminus. On a phylogenetic perspective, we
conclude that the pknG gene was present in mycobacteria
before the divergence of the fast-growing mycobacterial
species (M. smegmatis), from the slow-growing species
(pathogenic mycobacteria) (Shinnick and Good, 1994).
Fig. 1. Alignment of mycobacterial protein kinase G orthologues. PknG sequences from M. tuberculosis H37Rv (Rv0410c, from the Pasteur
Institute), M. marinum (MMAR_0713, from the Sanger Institute), M. avium paratuberculosis (MAP3893c, from TIGR), M. leprae (ML0304,
from the Sanger Institute) and M. smegmatis (MSMEG_0786, from TIGR) were aligned using CLUSTALW. The PknG orthologues of M. bovis
and M. microti were omitted since they were identical to M. tuberculosis PknG. The M. smegmatis PknG coding sequence starts at the ATG
that aligns to the start codon of M. tuberculosis PknG (see Fig. S1 online). Identical residues are shown in grey and the kinase domain is
underlined.
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In several non- or low-virulent bacteria, virulence genes
have been lost through deletion or acquisition of muta-
tions that either prevent the expression of a full-length
protein or give rise to an inactive product (Denecker et al.,
2002; Higashi et al., 2002; Roche et al., 2005). To deter-
mine whether the M. smegmatis open reading frame
encodes a functional kinase, as is predicted by its
sequence, His-tagged versions of M. smegmatis PknG as
well as M. bovis BCG PknG, which is identical to
M. tuberculosis PknG (Walburger et al., 2004), were
expressed in Escherichia coli, puriﬁed and their kinase
activity was analysed. As shown in Fig. 2, M. smegmatis
PknG was phosphorylated to a similar degree as M. bovis
BCG PknG. Furthermore, inclusion of the PknG speciﬁc
inhibitor AX20017 (Walburger et al., 2004; Scherr et al.,
2007) blocked autophosphorylation of both PknGs. We
conclude that the M. smegmatis pknG gene encodes a
orthologue of M. bovis BCG PknG that is an enzymatically
active serine/threonine kinase.
In vivo function of M. smegmatis PknG
We then investigated whether M. smegmatis PknG was
able to carry out the same in vivo function as PknG of
pathogenic mycobacteria, i.e. in blocking the fusion of
mycobacterial phagosomes with lysosomes. For this, a
PknG knockout of M. bovis BCG was transformed with
the plasmids pMV361-pknG smeg or pMV361-pknG BCG,
in which PknG expression was directed by the myco-
bacterial hsp60 promoter and translational initiation
sequences. The intracellular trafficking of the transfor-
mants was subsequently analysed after infection of bone
marrow-derived macrophages (Fig. 3). As observed pre-
viously, M. bovis BCGDpknG colocalized predominantly
with the lysosomal marker LAMP1, while wild-type
mycobacteria largely remained in LAMP1-negative vacu-
oles (Walburger et al., 2004). Importantly, this defect of
the mutant was complemented with either pMV361-
pknG BCG (Houben et al., 2006) or pMV361-pknG smeg. We
conclude that PknG from M. smegmatis is not only an
enzymatically active serine/threonine kinase, but is also
able to carry out the same biological function as PknG
of M. bovis BCG in blocking lysosomal delivery of
mycobacteria.
Expression of M. smegmatis PknG during in vitro growth
Initial experiments to investigate the expression of chro-
mosomal M. smegmatis pknG by immunoblotting using
antibodies against M. bovis BCG did not detect any
endogenous PknG in M. smegmatis (Walburger et al.,
2004). To determine whether this represented speciﬁcity
of the antibody for M. bovis BCG PknG, M. smegmatis
was transformed with the plasmids pMV361-pknG smeg
or pMV361-pknG BCG. Exponentially growing cultures of
these M. smegmatis transformants and M. bovis BCG
cultures were analysed by Western blotting using an
antiserum raised against PknGBCG (Fig. 4A). PknGsmeg
expressed in M. smegmatis from pMV361 was readily
recognized by the PknG antibodies (lane 10), to a similar
degree as PknG from M. bovis BCG expressed endog-
enously (lane 6) or in M. smegmatis from pMV361-
pknG BCG (lane 9). Furthermore, recombinant PknG from
M. bovis BCG and M. smegmatis that was produced in
E. coli and puriﬁed generated comparable signals after
immunoblotting (not shown). Therefore, the failure to
detect PknG in M. smegmatis was not due to a defect in
the cross-reactivity of the PknGBCG-speciﬁc antisera.
To explore the possibility that expression of PknG in
M. smegmatis was growth phase dependent, an overnight
culture of M. smegmatis was diluted to OD600 0.1 and
grown until the culture reached stationary phase (Fig. 4B).
Samples were taken for immunoblotting of bacterial
lysates at different time points during growth. As seen in
Fig. 4C, no PknG could be detected using anti-PknGBCG at
any stage during growth of M. smegmatis, showing that
PknG expression in M. smegmatis is not induced at a
particular growth phase.
Expression of M. smegmatis PknG after
macrophage infection
Although PknG is not detected in M. smegmatis growing
in vitro, it is possible that expression is upregulated
Fig. 2. Kinase activity of PknG. The kinase activity of PknG was
determined by incubation of 0.1 mg of puriﬁed M. bovis BCG and
M. smegmatis His-PknG in the absence or presence of the speciﬁc
PknG inhibitor AX20017 (1 mM) for 30 min at 37°C in a kinase
buffer (25 mM Tris/HCl pH 7.4, 2 mM MnCl2, 1 mM DTT and
3.7 ¥ 10
5 Bq [g-
32P]-ATP). The reactions were terminated by the
addition of SDS sample buffer and proteins were separated by 10%
SDS-PAGE, ﬁxed, dried and autoradiographed to determine the
phosphorylation of the PknGs. Results are representative data from
one experiment.
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To analyse this, bone marrow-derived macrophages
were infected with either M. smegmatis wild type or
M. smegmatis-expressing PknGBCG from pMV361. After
16 h of infection, cells were harvested, homogenized and
a post-nuclear supernatant was prepared and separated
by SDS-PAGE followed by immunoblotting. As can be
seen in Fig. 5, while PknG was readily observed in mac-
rophages that had been infected with M. smegmatis
expressing PknGBCG controlled by the hsp60 promoter, no
PknG was detected in cells that had phagocytosed
M. smegmatis. We therefore conclude that PknG is
not upregulated in M. smegmatis upon infection of
macrophages.
Selected ion monitoring analysis of total
M. smegmatis lysates
Finally, a more sensitive mass spectrometry-based
approach was adopted to detect PknG in M. smegmatis.
Selected ion monitoring analysis (SIM) of deﬁned
peptide masses was employed to analyse the presence
of PknG-derived peptides in M. smegmatis lysates. Total
proteins from M. smegmatis and M. smegmatis trans-
formed with pMV361-pknG smeg were separated by SDS-
PAGE. Proteins between 65 and 115 kDa were excised
from the gel (Fig. 6A), subjected to protease digestion
and analysed by mass spectrometry. Selected ion moni-
toring allowed the detection of two selected peptides 51
times in the wild-type M. smegmatis sample, while six
peptides (see Experimental procedures) were identiﬁed
3289 times in a lysate from M. smegmatis expressing
PknGsmeg in trans (Fig. 6B). These data, together with
the absence of a PknG signal following immunoblotting,
show that PknG is translated at extremely low levels in
M. smegmatis.
Transcription of pknG from M. smegmatis
The extremely low levels of PknG from M. smegmatis
could be explained by inefficient transcription of the pknG
gene. To analyse pknG transcription, total RNA was iso-
lated from M. smegmatis or M. bovis BCG and analysed
for the presence of pknG transcripts by RT-PCR (Fig. 7A).
Strikingly, a speciﬁc band could be ampliﬁed by RT-PCR
using M. smegmatis as well as M. bovis BCG RNA with
pknG-speciﬁc primers (only after reverse transcription),
indicating the presence of pknG RNA in M. smegmatis.
Sequencing conﬁrmed that this product was the
anticipated ampliﬁed fragment of the PknG transcripts
(not shown).
To accurately measure the levels of PknG transcripts in
M. bovis BCG and M. smegmatis, quantitative real-time
RT-PCR was carried out using in vitro synthesized
Fig. 3. Subcellular localization of M. bovis BCG in the absence or presence of PknG.
A. Bone marrow-derived macrophages were infected with M. bovis BCG (wt), M. bovis BCGDpknG (DpknG), M. bovis
BCGDpknG-pMV361-pknG
BCG (DpknG-pknG
BCG)o rM. bovis BCGDpknG-pMV361-pknG
smeg (DpknG-pknG
smeg) for 1 h, followed by a 2 h chase,
ﬁxed, permeabilized, and immunodecorated with antibodies raised against LAMP1 (rat) and M. bovis (rabbit). Anti-rat Alexa Fluor 568 (red)
and anti-rabbit Alexa Fluor 488 (green) were used as secondary antibodies. Scale bar, 5 mm.
B. For quantiﬁcations, cells containing mycobacteria in LAMP-positive vacuoles were scored. Results are mean values ( SD) from three
independent experiments (50 mycobacteria containing vacuoles were scored per experiment). Compared with M. bovis BCG (wt) only
non-complemented M. bovis BCGDpknG (DpknG) colocalized signiﬁcantly more with LAMP1 (*P < 0.05).
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Results are expressed relative to total cellular RNA or
protein. This allowed comparison of the differences in
pknG transcription relative to stable RNA (rRNA, tRNA)
or mRNA translation products in these cells (see Experi-
mental procedures). When normalized to stable RNA,
M. bovis BCG had a four times higher level of pknG tran-
script (Fig. 7C). When normalized to cellular protein
however, pknG mRNA levels in M. smegmatis were not
signiﬁcantly different (P = 0.23) compared with M. bovis
BCG (Fig. 7D). We conclude that the sharply decreased
levels of PknG in M. smegmatis as analysed by immuno-
blotting or MS analyses are mainly due to a reduced
translational efficiency.
Regulation of pknG translation
To address whether the severe difference in the transla-
tional efficiency of PknG between BCG and M. smegmatis
could be due to regulatory elements upstream of the two
pknG genes, fusion constructs were produced. The ribo-
some binding site (RBS) in the hsp60 promoter of
pMV361-pknG BCG and pMV361-pknG smeg was replaced
by the upstream region of the corresponding pknG genes.
Since pknG has been proposed to be the last gene of
an operon of three genes, the two upstream genes of
pknG were introduced (Fig. 8A; see also Experimental
procedures). In addition, the upstream regions were
exchanged between the constructs; the upstream region
Fig. 4. Expression of M. smegmatis PknG
during in vitro growth.
A. Lysates from M. bovis BCG (lane 1),
M. bovis BCGDpknG (lane 2), M. smegmatis
(lane 3), M. smegmatis-pknG
BCG (lane 4),
M. smegmatis-pknG
smeg (lane 5) were
separated on a 10% SDS-PAGE gel and
immunoblotted using anti-PknG
BCG antiserum
(right). The total protein pattern was analysed
by Ponceau Red staining (left).
B and C. M. smegmatis was grown in
7H9-OADC medium until stationary phase.
Bacterial samples were collected at different
time points (arrows in B) and analysed for the
presence of PknG by immunoblotting as
under A (C). BCG lysate was loaded in
parallel as a positive control (lane 1). Again,
the total protein pattern was analysed by
Ponceau Red staining (left). Results are
representative data from one experiment.
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pknG and visa versa. The constructs were subsequently
introduced in the ‘PknG minus’ background of M. bovis
BCGDpknG and PknG expression was analysed via
Western blotting and RT-PCR (Fig. 8B and C).
Exponentially growing cultures of the M. bovis BCG
transformants were analysed by Western blotting using an
antiserum raised against PknGBCG (Fig. 8B). PknGBCG
translationally controlled by its own upstream region in
pMV361 was clearly expressed in M. bovis BCGDpknG
(Fig. 8B, lane 9), and the product migrated similarly to
PknG from M. bovis BCG expressed endogenously
(Fig. 8B, lane 7). In contrast, no PknG signal was detect-
able after introduction of the construct containing
M. smegmatis pknG with its own upstream region
in M. bovis BCGDpknG (lane 10). This shows that
the low translation of PknGsmeg is not related to any
M. smegmatis-speciﬁc factors. However, introduction of
the construct, in which the M. smegmatis gene was fused
to the M. bovis BCG upstream region, resulted in clear
expression of M. smegmatis PknG (lane 11), while after
introduction of the construct containing BCG pknG with
the M. smegmatis upstream region no PknG signal could
be detected (lane 12). From this we conclude that the
upstream region of M. smegmatis pknG is solely respon-
sible for the virtual lack of expression of the M. smegmatis
gene.
To verify that the lack of expression of the pknG genes
fused to the M. smegmatis upstream region occurred on a
translational level, total RNA was isolated of M. bovis
BCG wt and the various BCG transformants and subse-
quently analysed for the presence of pknG transcripts by
RT-PCR (Fig. 8C). A speciﬁc band could be ampliﬁed by
RT-PCR only in the presence of the reverse trancriptase
(RT) using RNA from M. bovis BCG wt and all M. bovis
BCGDpknG tranformants, except M. bovis BCGDpknG
that was transformed with the empty vector (lane 5). We
can therefore conclude that the lack of PknG expression
Fig. 5. Expression of M. smegmatis PknG during macrophage
infection. PknG immunoblot of macrophages infected for 16 h with
M. smegmatis or M. smegmatis expressing PknG
BCG. After infection,
cells were harvested, homogenized and a post-nuclear supernatant
was submitted to immunoblotting (lanes 3 and 4). The total protein
pattern was analysed by Ponceau Red staining (lanes 1 and 2).
Results are representative data from one experiment.
Fig. 6. Selected ion monitoring analysis of
M. smegmatis lysates.
A. Lysates (10 mg) from M. smegmatis and
M. smegmatis-pknG
smeg were separated on a
10% SDS-PAGE gel, followed by Coomassie
Blue staining (lanes 1 and 2) or
immunoblotting using anti-PknG
BCG antiserum
(lanes 3 and 4).
B. Thirty micrograms of the same lysates as
analysed under (A) were separated on a 10%
SDS-PAGE gel and stained with Colloidal
Blue. The region between 65 and 115 kDa
was excised (indicated by the rectangles in
A), digested with trypsin and the obtained
peptides were identiﬁed using selected ion
monitoring (see Experimental procedures).
Representative data from two independent
experiments are shown.
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fused to the upstream region of M. smegmatis is caused
by a expression failure on a translational level.
Discussion
Pathogenic mycobacteria survive within macrophages
by preventing fusion of mycobacterial phagosomes with
lysosomes (Armstrong and Hart, 1971; Russell, 2001;
Houben et al., 2006). A crucial molecule involved in the
modulation of phagosome lysosome fusion is PknG, a
eukaryotic-like mycobacterial serine/threonine kinase
(Walburger et al., 2004). Notably, while PknG functions as
an important virulence factor in pathogenic mycobacteria,
a pknG gene is also found in a saprophytic species,
M. smegmatis. Here we show that when expressed from
expression vectors, M. smegmatis pknG encodes an
enzymatically active serine/threonine kinase that provides
normal biological activity in the survival of mycobacteria
inside macrophages. However, virtually no translation
product of endogenous pknG was detected either when
M. smegmatis was grown in vitro or within macrophages
under the conditions examined here. Quantitative tran-
scriptional assays showed that the sharply reduced
expression in M. smegmatis could not be attributed to
mRNA levels, showing that PknG expression is blocked
on a post-transcriptional level in this non-pathogenic
mycobacterium.
Replacement of the upstream regions of M. smegmatis
and M. bovis BCG pknG by vector-encoded transcriptional
and translational expression sequences resulted in similar
levelsofPknGsmegandPknGBCGexpressioninM. smegma-
tis. This led to the conclusion that the differences in accu-
mulation of pknG gene products could be caused neither
by post-translational mechanisms such as host-speciﬁc
proteases, nor by the codon usage within the pknG genes.
The latter is in agreement with the observation that the
codon biases of M. smegmatis and M. bovis BCG pknG,
represented by their codon adaptation indices (de Miranda
et al., 2000), do not signiﬁcantly differ (not shown).
However, replacing the vector-encoded translational
expression sequences by their own or each others
upstream regions of the pknG genes, while keeping the
transcriptional sequences of the vector intact, clearly
showedthatelementsintheupstreamregionsofthegenes
cause the differences in translation efficiencies. A typical
upstream translational regulatory element is the ribosome
binding site and it is a possibility that the ribosome binding
site of M. smegmatis pknG is very inefficient.Alternatively,
recognition of the upstream region by regulatory RNA,
proteins or metabolites might cause the differences in
translational efficiencies between mycobacterial species.
Western blot analysis for the expression of PknG in a
wide range of mycobacterial species grown under similar
growth conditions revealed that only some of the slow-
growing pathogenic species, mainly the members of the
M. tuberculosis complex and species closely related to
the M. tuberculosis complex, expresses PknG, while none
of the analysed non-pathogenic, fast-growing species
showed PknG expression (Fig. 9). Notably, all mycobac-
terial genomes, of which sequence data are available at
this moment (from both pathogenic and non-pathogenic
Fig. 7. Analysis of pknG transcription in
M. smegmatis.
A. cDNA was prepared from total M. bovis
BCG and M. smegmatis RNA by using
reverse transcriptase and random primers.
cDNA of pknG was ampliﬁed using
gene-speciﬁc primers. As a control the same
reactions were carried out without reverse
transcriptase (-RT) or without RNA (H2O).
B. Standard curves for M. bovis BCG and
M. smegmatis pknG TaqMan primer/probe
sets were constructed from serial dilutions of
known quantities of in vitro synthesized
transcripts. Threshold cycle (Ct) values were
plotted against copies of transcripts.
C and D. PknG mRNA expression in M. bovis
BCG and M. smegmatis per pg of total RNA
(C) and per pg of total protein (D). Copies
pg
-1 total RNA were calculated from the
standard curves shown in (B). These values
were subsequently corrected by the
RNA : protein ratio (see Experimental
procedures) to calculate the number of PknG
mRNA copies pg
-1 total protein. Results are
mean values (SD) from three RNA
isolations. M. smegmatis PknG mRNA levels
were not signiﬁcantly different from M. bovis
BCG PknG mRNA levels (P > 0.05).
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conserved in all mycobacterial species, which implies that
not only in M. smegmatis, but in more mycobacterial
species PknG expression is suppressed.
The availability of a growing number of mycobacterial
genome sequences allows comparisons that may help to
identify genes corresponding to strain-speciﬁc pathoge-
nicity functions (Cole et al., 2001). Our studies suggest
the existence of another subset of genes whose relative
levels of expression, and not their presence or absence,
deﬁnes virulence in mycobacterium. It is important to rec-
ognize that the changes on the level of expression that
determine pknG activity in different species might be
achieved by the evolution of regulatory systems that
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cation and analysis of these regulatory systems may
provide new strategies to combat important mycobacterial
diseases such as tuberculosis and leprosy.
Experimental procedures
Cell lines, bacterial strains and antibodies
Mycobacterium bovis BCG Pasteur was provided by the Insti-
tut Pasteur (Paris, France) and M. smegmatis mc
2155 was
from ATCC (ATCC 700084). Disruption of pknG in the
M. bovis BCG Pasteur was carried out as described (Wal-
burger et al., 2004). Mycobacteria were grown in 7H9
mycobacterial medium supplemented with 10% OADC
Middlebrook supplement (Difco Laboratories). Bone marrow-
derived macrophage isolation from C57/BL6 mice, anti-
LAMP1 monoclonal antibodies, secondary reagents and the
PknG inhibitor AX20017 have been described (Ferrari et al.,
1999; Gatﬁeld and Pieters, 2000; Walburger et al., 2004).
Antibodies against PknG were raised by Eurogentec in New
Zealand white rabbits against His-tagged recombinant PknG
that was expressed in E. coli and puriﬁed as described (Wal-
burger et al., 2004). PknG-speciﬁc IgGs were further puriﬁed
using a HiTrap Protein A column, followed by a HiTrap NHS-
activated column coupled with His-tagged recombinant PknG
(both supplied by GE Healthcare Bio-Sciences). Polyclonal
rabbit antibodies against M. bovis were purchased from Dako
Corporation.
Cloning of PknG expression vectors
Anchored primers (EcoRI–NdeI for the 5′ primer and NdeI–
HindIII for the 3′ primer) were used to amplify pknG from
M. smegmatis genomic DNA by PCR, cloned in pGEM-T-
Easy (Promega) and sequenced (Applied Biosystems). After
sequencing, the genes were cloned as EcoRI–HindIII frag-
ments in pMV361 (Stover et al., 1991) and in pBAD/His B
(Invitrogen Life Technologies). The resulting plasmids
were designated pMV361-pknG
smeg and pBad-PknG
smeg. An
anchored 5′ primer (AclI-BCG0451c.fw containing an AclI
site; see Table S1) and a 3′ primer recognizing a sequence
downstream of the AclI site in M. bovis BCG pknG (BCG-Pk-
EcoRV.rev) were used to amplify pknG together with 2345 bp
upstream region (containing BCG0431c and glnH including
40 bp upstream of BCG0431c) from M. bovis BCG genomic
DNA by PCR and cloned AclI–AclI in pMV361-pknG
BCG (Wal-
burger et al., 2004), designated pMV361-BCG-pknG
BCG (see
also Fig. 8A). Since theAclI site in the hsp60 promoter region
of pMV361 is located upstream of the ribosome binding site,
but downstream of the transcription start (Stover et al., 1991),
only the transcription start of hsp60 is left in this construct.
Similarly, an anchored 5′ primer with an AclI site (AclI-
MSMEG_0788.fw) was used together with a 3′ primer recog-
nizing the XmnI site in M. smegmatis pknG (Smeg-XmnI.rev)
to amplify M. smegmatis pknG together with the 2423 bp
upstream region (containing MSMEG_0788, MSMEG_0787
and 40 bp upstream of MSMEG_0788) from M. smegmatis
genomic DNA and cloned AclI–XmnI into pMV361-pknG
smeg
(this study), resulting in pMV361-smeg-pknG
smeg. In addition,
the upstream regions of the two genes were exchanged by a
nested PCR approach (by using the 5′ anchor primers, the 3′
AclI or XmnI primer and internal overlapping primers; for
primer sequences see Table S1), resulting in pMV361-BCG-
pknG
smeg for pknG
smeg with the upstream region of pknG
BCG
and pMV361-smeg-pknG
BCG for pknG
BCG together with the
upstream region of pknG
smeg. All constructs were sequenced
(Applied Biosystems) and electroporated into M. smegmatis
mc
2155 and/or M. bovis BCGDpknG Pasteur (Parish and
Stoker, 1998).
Expression and puriﬁcation of M. smegmatis PknG
For expression and puriﬁcation of M. smegmatis PknG, E. coli
strain BL21 was transformed with pBAD-PknG
smeg. Transfor-
mantsweregrowninLBmediumcontaining100 mgm l
-1ampi-
cillin and 0.2% glucose at 37°C until the OD600 reached 0.45.
Bacteria were pelleted (4200 g for 10 min) and re-suspended
in LB medium containing 100 mgm l
-1 ampicillin and 0.2%
arabinose. Bacteria were grown for another 4 h at 37°C and
harvested (4200 g for 10 min at 4°C). (His)6-PknG
smeg was
puriﬁed via a Ni
2+-loaded HisTrap chelating column from GE
Healthcare Bio-Sciences using an imidazole gradient as
described (Walburger et al., 2004).
Biochemical methods
Homogenization of mycobacterial lysates was performed and
kinase activity of puriﬁed kinase was measured as described
(Walburger et al., 2004).
RT-PCR and qRT-PCR
Isolation of RNA samples from M. bovis BCG and
M. smegmatis, DNase treatments, cDNA synthesis and the
Fig. 8. Analysis of the inﬂuence of the upstream region of M. smegmatis and M. bovis BCG pknG on pknG expression.
A. Schematic representation of the fusion constructs used in this experiment. All constructs were introduced in the pMV361 vector at the AclI
restriction site in the hsp60 promoter leaving the transcription (Tc) start intact (see also Experimental Procedures). pMV361-BCG-PknG
BCG,
pMV361 with M. bovis BCG pknG and its own upstream region; pMV361-smeg-PknG
smeg, pMV361 with M. smegmatis pknG and its own
upstream region; pMV361-BCG-PknG
smeg, pMV361 with pknG
smeg fused to the M. bovis BCG pknG upstream region; pMV361-smeg-PknG
BCG,
pMV361 with pknG
BCG fused to the M. smegmatis pknG upstream region.
B. Lysates from M. bovis BCG (lane 7) and M. bovis BCGDDpknG transformed with empty vector (lane 8) or the plasmids shown under (A)
(lanes 9–12) were separated on a 10% SDS-PAGE gel and immunoblotted using anti-PknG
BCG antiserum (right). The total protein pattern was
analysed by Ponceau Red staining (left).
C. cDNA was prepared from total RNA isolated from M. bovis BCG wt and the M. bovis BCGDpknG transformants analysed under (B) by using
reverse transcriptase and random primers. cDNA of pknG was subsequently ampliﬁed using gene-speciﬁc primers. As controls the same
reactions were carried out without reverse transcriptase (-RT) or in stead of pknG primers with 16S rRNA-speciﬁc primers. Representative
data from three experiments are shown.
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A. Lysates of various mycobacterial species were separated on a 10% SDS-PAGE gel and immunoblotted using anti-PknG antiserum
(bottom). The total protein pattern was analysed by Ponceau Red staining (top). For sources and growth conditions of the mycobacterial
species see Table S2.
B. Phylogenic tree of mycobacteria based on 16S rRNA gene sequences. Species that show a PknG signal in (A) are boxed in green, the
ones that do not show expression are boxed in red. Tree adapted from Springer et al. (1996).
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et al., 2005). The protein concentration of the mycobacterial
lysates and the amount of RNA isolated from these lysates
were determined using a Bradford protein assay and the
NanoDrop spectrophotometer respectively. Protein and RNA
concentrations were additionally veriﬁed on SDS-PAGE and
agarose gels respectively. Ampliﬁcation of pknG cDNA from
M. bovis BCG and M. smegmatis was carried out using the
same primers (RT-PknG.fw and RT-PknG.rev in Table S1).
As a control, transcription of the 16S rRNA gene (16S-
RNA.fw and 16S-RNA.rev in Table S1) was analysed as well.
The same RNA samples were used for quantitative
RT-PCR. In addition, M. bovis BCG and M. smegmatis PknG
transcripts were synthesized from HindIII linearized pET15b-
PknG
BCG (Walburger et al., 2004) and pGEM-T-Easy-
PknG
smeg using the T7 RiboMAX express large-scale RNA
production system (Promega) and used as standards. Quan-
titative, real-time, one-step RT-PCR was carried out using the
Applied Biosystems 7500 Sequence Detection Systems
(SDS). Sets of primer pairs and a TaqMAN probe (Table S1)
were designed and qRT-PCR was performed using the Quan-
tiTect probe RT-PCR kit (QIAGEN). Fluorescence data were
analysed using the Applied Biosystems Sequence Detection
software version 1.2.3. Each reaction was run in duplicates.
Sample preparation for mass spectrometric analysis
The region between 65 and 100 kDa of each entire lane was
excised followed by in-gel trypsin digestion as described
(Granvogl et al., 2006).
Nano-LC-IT-SIM-MS analysis
The resulting peptides from each gel piece were analysed by
liquid chromatography (LC) coupled to a LTQ ion trap mass
spectrometer (Thermo Electronics) equipped with a nano-LC
electrospray ionization source. Peptides were dissolved in
bufferA(1% formic acid, 0.5% acetic acid, 0.012% heptaﬂuo-
robutyric acid) and concentrated and desalted online on a
C18 PepMap 100 micro precolumn (5 mm particle size,
300 mm ¥ 1 mm; Dionex Corporation) that was coupled
to a self-packed (7 cm, 3 mm; ProntoSil C18-ACE-EPS,
Bischoff Chromatography) and pulled (P-2000 laser puller,
Sutter Instrument) fused silica capillary (100 mm inner
diameter ¥ 365 mm outer diameter). The chromatographic
separation was then performed by a 100 min non-linear gra-
dient from 5–55% buffer B (80% acetonitrile/0.5% aceticAcid/
0.012% HFBA) with a constant ﬂow rate of 0.20 ml min
-1. The
mass spectrometric data acquisition was performed with a
survey scan (450–1500 m/z) followed by ﬁve selected ion
monitoring scans (SIM). The selected masses correspond to
the following peptides: LGGGLVEIPR [MH2
+ 505.8], LIDL-
GAVSR [MH2
+ 472.28], TGPTVATDIYTVGR [MH2
+ 725.88],
LTSAVTLLSGR [MH2
+ 559.33], TLAALTLDLPTR [MH2
+
642.88] and ALLDLGDVAK [MH2
+ 507.28]. The collision
energy was set to 35%.
Database searching for protein identiﬁcation
SEQUEST (Bioworks, Thermo Electron Corporation) was
used to search the SWISSPROT database (UniprotKB/
Swiss-Prot) supplemented with the corresponding pknG
sequence of M. smegmatis for peptide sequence and protein
identiﬁcation. Search parameters included differential mass
modiﬁcation to methionine due to possible oxidation and
static mass modiﬁcation to cysteine due to alkylation by
iodoacetamide. Furthermore, one missed cleavage of trypsin
was accepted.
Statistical analysis
Data were statistically analysed using the Student’s t-test and
differences were considered signiﬁcant if the P-value was
< 0.05.
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